My wife owns a lot of CVS stock and since they are a PBM, do we think TrumpRx and others in the pipeline are going to actually take a chunk from PBM? Or since those are manufacture direct will not be taking insurance, so the PBMs will actually make more money by shaking out the cash buyers?